An Observational Study of Coronary Microvascular Disease of China
CCMD
China Coronary Microvascular Disease(CCMD) Registry
1 other identifier
observational
500
1 country
1
Brief Summary
Non-obstructive coronary heart disease refers to patients with angina pectoris without significant narrowing of the epicardial vessels. Coronary microvascular disease(CMD) is a kind of non-obstructive coronary heart disease, and its clinical detection rate is increasing, seriously affecting the quality of life of patients, and increasing the risk of cardiovascular adverse events, but its mechanism has not been fully understood. This study will prospectively collect patients who meet the diagnosis of CMD, observe the development and outcome of the disease, and explore its occurrence and development mechanism.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2024
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 4, 2024
CompletedFirst Posted
Study publicly available on registry
November 6, 2024
CompletedStudy Start
First participant enrolled
November 11, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 10, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
October 10, 2029
August 20, 2025
August 1, 2025
3.9 years
November 4, 2024
August 19, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Establish a Registry of CMD patients in China
5 years
Eligibility Criteria
The patient had obvious symptoms of angina pectoris, but coronary angiography showed no obvious epicardial stenosis, and auxiliary examinations such as ultrasound, CTP,CMR, PET, SPECT, and coronary function examination indicate the presence of microcirculation dysfunction
You may qualify if:
- Angina symptoms
- Objective evidence of myocardial ischemia
- Coronary angiography was normal,irregular tube wall, or stenosis \<50%
You may not qualify if:
- People under the age of 18
- Non-cardiogenic chest pain and other heart conditions such as variant angina, cardiomyopathy, myocarditis or valvular heart disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Fuwai central China cardiovascular hospotial
Zhengzhou, 450003, China
Biospecimen
Blood, saliva, stool and urine samples
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
muwei li, Ph.D
Fuwai central China cardiovascular hospotial
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Target Duration
- 3 Years
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 4, 2024
First Posted
November 6, 2024
Study Start
November 11, 2024
Primary Completion (Estimated)
October 10, 2028
Study Completion (Estimated)
October 10, 2029
Last Updated
August 20, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will not share